↓ Skip to main content

Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity

Overview of attention for article published in Cancer Immunology Research, September 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#9 of 1,387)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity
Published in
Cancer Immunology Research, September 2022
DOI 10.1158/2326-6066.cir-21-1075
Pubmed ID
Authors

Alfonso R. Sánchez-Paulete, Jaime Mateus-Tique, Gurkan Mollaoglu, Sebastian R. Nielsen, Adam Marks, Ashwitha Lakshmi, Jalal A. Khan, C. Matthias Wilk, Luisanna Pia, Alessia Baccarini, Miriam Merad, Brian D. Brown

Twitter Demographics

The data shown below were collected from the profiles of 28 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 22%
Professor > Associate Professor 2 22%
Student > Master 2 22%
Student > Doctoral Student 1 11%
Student > Bachelor 1 11%
Other 1 11%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 44%
Immunology and Microbiology 3 33%
Agricultural and Biological Sciences 1 11%
Unknown 1 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 157. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2022.
All research outputs
#212,043
of 22,557,763 outputs
Outputs from Cancer Immunology Research
#9
of 1,387 outputs
Outputs of similar age
#5,721
of 342,556 outputs
Outputs of similar age from Cancer Immunology Research
#1
of 30 outputs
Altmetric has tracked 22,557,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,387 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,556 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.